Susan Matesanz, MD

Abstracts

2020

Gross, B., Matesanz, SE., Kichula, EA. Shortening Treatment Initiation Timeframe Through Prenatal/Neonate Genetic Diagnosis of Spinal Muscular Atrophy. Philadelphia Prenatal Conference. Virtual presentation due to COVID19 pandemic.

Matesanz, SE., Kichula, EA., Brandsema, JF., Yum, SW. Muscle ultrasound as a tool for identification of early disease manifestation in SMA patients identified by newborn screen. Accepted to the Muscular Dystrophy Association 2020 Annual Conference; March 2020 in Orlando, FL. Conference cancelled due to COVID-19.

Matesanz, SE*., Edelson, JB*., Iacobellis, KA., Mejia, E., Brandsema, JF., Griffis, H., Okunowo, O. Lin, KY. Characteristics of Healthcare Users in Pediatric Patients with Muscular Dystrophy in the United States. Accepted to the Muscular Dystrophy Association 2020 Annual Conference; March 2020 in Orlando, FL. *co-first authors. Conference cancelled due to COVID-19.

Edelson, J., Matesanz, S., Iacobellis, K., Mejia, E., Brandsema, J., Griffis, H., Okunowo, O. Lin, K. Health Care Utilization in Pediatric Patients with Muscular Dystrophy in the United States. J Am Coll Cardiol. 2020 Mar, 75 (11 Supplement 1) 1096.

2019

Matesanz, S., Brandsema, J., Mayer, O., Kichula, E. Comparing Hospital Respiratory Outcomes Pre- and Post- Nusinersen Treatment in Children with Spinal Muscular Atrophy.  Presented at the Child Neurology Society Annual Conference, Charlotte NC, October 2019. Annals of Neurology Vol 86 (suppl 23) 2019. S125.181.

2018

Hopkins, S., Gordon-Lipkin, E., VanHaren, K., Santoro, J., Munoz-Arcos, L., Matesanz, S., et al. MRI Brain Abnormalities in Acute Flaccid Myelitis: Characteristics and Differentiation from Acute Disseminated Encephalomyelitis. Presented at American Academy of Neurology annual meeting 2018. Neurology Apr 2018, 90 (15 Supplement) P5.145

Posters and Presentations

Presentations

2020

Matesanz, SE., Battista, V., Jones, J., Flickinger, J., Kichula, EA. Early Single Center Clinical Experience with Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) Type 1 and 2 Patients over Age 7 Months. Oral presentation at virtual CureSMA conference. 

Publications

2020

Matesanz, SE., Curry C., Gross B., Rubin, AI., Linn, R., Yum SY., Kichula, EA.  Clinical Course in a Patient with Spinal Muscular Atrophy Type 0 Treated with Nusinersen and Onasemnogene Abeparvovec. J Child Neurol. In press. doi:10.1177/0883073820928784

Cuddapah, V., Matesanz, S., Yum, S., Banwell, B., Stephenson, D. Peripheral Neuropathy Caused by Vitamin B12 Deficiency: Vitamin B12 Deficiency was Precipitated by Nitrous Oxide in a Child with Autism. Pract Neurol. Mar/Apr 2020: 64-67.

2019

Matesanz, S., McGuire, J., & Hopkins, S. Acute Flaccid Myelitis: Characteristics and Outcomes of 2014 and 2016 Cases at a Single Center. J Pediatr 2019;215:272-6. doi: 10.1016/j.jpeds.2019.07.015.

Matesanz, S., Kotch, C., Perrone, C., Waanders,A., Hill, B., Narula, S. Expanding the MOG Phenotype: Brainstem Encephalitis with punctate and curvilinear enhancement. Neurology: Neuroimmunology and Neuroinflammation. Neurol Neuroimmunol Neuroinflamm. 2019 Sep 13;6(6). pii: e619. doi: 10.1212/NXI.0000000000000619. Print 2019 Nov.

2016

Maza, M., Matesanz, S., et al. Adherence to recommended follow-up care after high grade cytology in El Salvador. International Journal of Healthcare 2: 31-36, 2016.